Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures, bringing total Series D Financing to $95 Million

New York, Aug. 10, 2022 (GLOBE NEWSWIRE) — HIGHLIGHTS: ●      Insilico Medicine announces a closing of its Series D2 round, bringing the total Series D financing to $95 million, despite an uncertain market ●       The Series D2 round is led by Prosperity7, the diversified growth fund of Aramco Ventures, which is […]

New York, Aug. 10, 2022 (GLOBE NEWSWIRE) — HIGHLIGHTS:

●      Insilico Medicine announces a closing of its Series D2 round, bringing the total Series D financing to $95 million, despite an uncertain market

●       The Series D2 round is led by Prosperity7, the diversified growth fund of Aramco Ventures, which is an investment subsidiary of Aramco, the world’s leading integrated energy and chemicals company

●    Relying on Prosperity7’s global network and generous resources, Insilico will expand its AI capabilities from drug R&D to multiple areas to support sustainable development

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a second closing of its Series D round, led by Prosperity7 Ventures, the diversified growth fund of Aramco Ventures, bringing the total Series D financing to $95 million. Other global investors with expertise in the biopharmaceutical and life sciences sectors also participated.

The financing brought in Prosperity7 as a new investor, alongside current investors in the Series D round, including a large, diversified asset management firm on the US West Coast, B Capital Group, Warburg Pincus, BHR Partners, Qiming Venture Partners, Deerfield, Pavilion Capital, BOLD Capital Partners, and WS Investment Company. Insilico’s founder and CEO, Alex Zhavoronkov, PhD, also invested in the Series D round.

Aysar Tayeb, Executive Managing Director of Prosperity7 Ventures, said: “The deepening application of AI and machine learning for drug discovery has demonstrated a transformative positive impact on the pharmaceutical industry and we are delighted to embark on this partnership with Insilico Medicine, a frontrunner in this innovation. Backed by the breadth of Aramco’s ecosystem across geographies and sectors, we look to support the company to scale up and expand its footprint globally, to drive biotechnology excellence, and to bring positive impact for greater wellbeing.”

The new Series D capital will support the continued advancement of Insilico’s pipeline, including its lead program which is currently in a Phase 1 study in New Zealand and in China, as well as several pipeline programs in IND-enabling studies. The proceeds will also fund other key strategic initiatives, including further development of its end-to-end Pharma.AI platform, the launch of a fully automated, AI-driven robotic drug discovery laboratory and biological data factory, and the establishment of regional centers.

The investment from Prosperity7 further diversifies the Company’s investor base globally and brings a potential strategic partner with deep expertise in high-performance and environmentally friendly energy R&D. Relying on Prosperity7’s global network and generous resources, Insilico will expand its AI capabilities from drug R&D to multiple areas, including sustainable chemistry, green energy, and agriculture to actively support sustainable development. Insilico had already leveraged the power of its platform to accelerate innovation in sustainable agriculture in a multi-year collaboration with Syngenta which validated that the platform’s capabilities in AI-enabled multiparameter optimization could create substantial value.

“In 2022, Aramco became the world’s most valuable company, and we are deeply honored to receive the investment from their venture capital arm, Prosperity7, which focuses on investment in ‘disruptive technology’,” said Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine. “Our experience in expanding our reach into sustainable agriculture through our collaboration with Syngenta and others demonstrated the diversity of data and methods and unprecedented scale up allows us to improve our performance. I am certain that the collaborations with Prosperity7 in the field of sustainable and environmentally friendly chemistry and clean energy solutions will further expand our artificial intelligence capabilities. In addition, after spending time in Saudi Arabia, it is clear that the country is making a giant leap in technology. We would love to be part of this effort and help the country realize its vision using the latest advances in artificial intelligence.”

Through a unique dual-CEO structure, Insilico Medicine is advancing its AI capabilities and drug research and development simultaneously. Recently, the Company promoted Dr. Feng Ren, Insilico’s Chief Scientific Officer (CSO) to the position of co-CEO to drive the company’s drug R&D platform. In addition to overseeing drug discovery and development, Dr. Ren will also guide the Company’s growing clinical development and will play a leading role in driving business development. During his tenure, the Company has rapidly transformed its pipeline into a robust portfolio of novel, innovative drug candidates, targeting areas with highly unmet needs. Seven programs in its internal pipeline have progressed to IND-enabling studies, including a novel 3CL protease inhibitor for COVID-19 treatment, and two synthetic lethality programs targeting MAT2A and USP1 for oncology indications. It also successfully completed a Phase 0 microdose study in Australia and entered Phase I clinical trials with its first internally developed program targeting fibrosis in both New Zealand and China.

“We have the structure to be as an equal parts AI and drug development company,” said Feng Ren, PhD, co-CEO and CSO of Insilico Medicine. “We also have a number of exciting initiatives in motion – including an expanding global presence, a robotics lab in development, and significant progress in our internal pipeline programs. With this latest funding round, we will be able to scale up our capabilities, advance our internal programs, develop our AI, and align with partners in the Saudi region to develop new regional technology hubs.”

Insilico has co-development and software licensing deals with a number of major pharmaceutical companies. Since the launch of its PandaOmics™ and Chemistry42™ platforms in late 2020, nine out of the top 20 pharmaceutical companies, as measured by 2020 revenue, have used Insilico’s AI platforms. In 2022, Insilico signed multi-asset partnerships with Fosun Pharma and EQRX in January and March, respectively. Notably, Insilico achieved its first major milestone and nominated a preclinical candidate for the QPCTL program for cancer immunotherapy less than 40 days into the strategic collaboration with Fosun Pharma.  Business development continues to remain a vital part of the company’s strategy to demonstrate and unlock the value of its Pharma.AI platform.

About Insilico Medicine

Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques to discover novel targets and to design novel molecular structures with desired properties. Insilico Medicine is delivering breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases and aging-related diseases.

For more information, visit www.insilico.com

For media inquiries, please contact media@insilicomedicine.com

About Prosperity7 Ventures

Prosperity7 Ventures is the diversified growth fund of Aramco Ventures, a subsidiary of Aramco, the world’s leading integrated energy and chemicals company. The fund’s name is derived from ‘Prosperity Well’, the 7th oil well drilled in Saudi Arabia and the first to strike oil. Taking forward this pioneering history, we invest globally, with a long term-view, in breakthrough technologies and transformational business models that will bring prosperity and positive impact on a vast scale.

For more information, visit www.prosperity7vc.com

Brita Belli
Insilico Medicine
475-225-0843
brita@insilico.com

OKX and LinkedIn Co-author Global Blockchain Industry Talent Report

The supply and demand of talent in the global blockchain field are out of balance, with candidates in short supply The demand for core talent has shifted from financial-oriented to technical focused The average tenure of global blockchain talents is 1.2 years, the turnover rate is high, and the flow of talent is mainly within […]

  • The supply and demand of talent in the global blockchain field are out of balance, with candidates in short supply
  • The demand for core talent has shifted from financial-oriented to technical focused
  • The average tenure of global blockchain talents is 1.2 years, the turnover rate is high, and the flow of talent is mainly within the blockchain industry

VICTORIA, Seychelles, Aug. 10, 2022 (GLOBE NEWSWIRE) — OKX, the world-leading cryptocurrency platform and LinkedIn, the world’s largest professional network, have co-authored a report that highlights the imbalance between the supply and demand of qualified talent in the global blockchain industry.

The in-depth research, based on LinkedIn’s exclusive big data analysis, took data from 180 countries in the period between January 2019 and June 2022. It covers the blockchain sector, as well as sub-industries that include the cryptography, quantum computing and distributed ledger sectors, as well as more than 15 other related sub-industries.

The report reveals that, as of June 2022, the supply and demand of talent in the global blockchain field are out of balance, with qualified candidates in short supply. The total number of LinkedIn members working in the blockchain field has increased by 76% year-on-year, but the major countries that blockchain sector candidates have traditionally come from are experiencing negative talent growth. China, where growth is stable, is the exception to this trend.

Haider Rafique, Chief Marketing Officer, OKX, said: “The results of the study we have conducted with LinkedIn reflect our own ongoing search for great talent at OKX. We announced previously that we were going to increase our headcount by 30% by the end of next year and this remains true. I am confident that OKX’s leadership among crypto exchanges, our determination to constantly innovate and improve the user experience, and our certainty that blockchain and Web 3.0 is the future will allow us to continue to attract the best talent.”

The research also shows that the demand for core talent has shifted from financial-oriented to candidates with technical skills. In terms of number of job postings, R&D specialists top the global demand, followed by information technology. Product management, marketing and human resources job offerings are not far behind. From the perspective of recruitment demand, financial candidates are now ranked in the sixth position.

Another challenge highlighted by the report involves the short tenure of candidates and the high turnover rate. The ‘LinkedIn Global Talent Big Data Insights’ report shows that the average tenure of global blockchain talent is 1.2 years. The report also shows that in addition to the influx of talent from traditional financial and technology companies, talent movement in the global blockchain industry is mainly based on intra-industry flow.

Linda Tse, Global Talent Acquisition Lead, OKX said: “As a booming frontier industry that is affected by the talent trends of the entire blockchain sector, the competition for high-quality candidates and the frequent movement of talent is somewhat inevitable. That being said, OKX’s strong focus on innovation, professional development, work-life balance and our mission-driven mindset are supporting our talent growth strategy. We received almost 19,000 job applications in May of 2022, and this number has only kept on increasing”

The full OKX/LinkedIn Global Blockchain Industry Talent Report can be found at OKX.com and on LinkedIn.

For further information, please contact:
Media@okx.com

About OKX
OKX is a leading crypto trading app, and a Web3 ecosystem. Trusted by more than 20 million global customers in over 180 international markets, OKX is known for being the fastest and most reliable crypto trading app of choice for investors and professional traders globally.

To learn more about OKX, download our app or visit: okx.com

Lakemore Partners Appoints Paul Gyra as Chair of Audit Committee

PHOENIX and LONDON and DUBAI, United Arab Emirates, Aug. 10, 2022 (GLOBE NEWSWIRE) — Lakemore Partners Ltd. and its group entities (“Lakemore”), a leading private credit investment firm primarily investing in control CLO equity, today announced it has appointed Paul Gyra as the independent Chair of the Lakemore Partners Audit Committee. Mr. Gyra is a […]

PHOENIX and LONDON and DUBAI, United Arab Emirates, Aug. 10, 2022 (GLOBE NEWSWIRE) — Lakemore Partners Ltd. and its group entities (“Lakemore”), a leading private credit investment firm primarily investing in control CLO equity, today announced it has appointed Paul Gyra as the independent Chair of the Lakemore Partners Audit Committee. Mr. Gyra is a seasoned business executive with over three decades of experience in investment banking and asset management.

“We are thrilled to have appointed Paul as Chair of our Audit Committee,” said Ahmed Farid, Chairman and President of Lakemore. “Paul’s deep understanding of our firm’s culture and years of expertise spearheading cross-border strategies will serve Lakemore well as we further establish and maintain longstanding partnerships with our clients and top-tier CLO collateral managers across the world.”

In addition to his roles at Lakemore, Mr. Gyra also serves as Managing Partner at the Thompson Family Office, where he helps to execute on the development of Smart, Sustainable City outside of Washington, DC, and development of direct investment programs with like-minded Family Office Partners that have a social and environmental impact. Previously, Mr. Gyra served as Managing Partner at Global Investment Bank Limited, where he was responsible for cross-border transactions and business development. Prior to that, Mr. Gyra was the Chief Operating Officer, Head of Strategy and Managing Partner at Safanad Limited, where he was responsible for the principal investment firm’s business operations and strategy across its Dubai, New York and London offices. Mr. Gyra also held CEO positions at ING Alternative Asset Management in New York, and Baring Asset Management – North America.

“I am confident that my familiarity with the firm will serve me well in this new role,” said Mr. Gyra. “I look forward to continuing to work closely with the team and Board to provide Lakemore’s global clientele of institutional investors with best-in-class service.”

Mr. Gyra is a CPA and received his BS Summa Cum Laude from Providence College, and attended the Advanced Management Program at Harvard Business School.

About Lakemore Partners

Lakemore is a leading private credit investment firm primarily investing in control CLO equity. Serving as a partner of choice for global top-tier collateral managers in the CLO market who are aligned to the firm’s portfolio management style and risk appetite, Lakemore aims to deliver attractive returns by leveraging the extensive expertise of its dedicated team and by investing within its well-defined framework of cycle-aligned risk allocation. Founded in 2016, Lakemore has offices in Phoenix, London and Dubai. Lakemore’s mission focuses on providing sustainable and reliable income, with the firm currently managing US$1.3 billion in credit assets under management, the majority of which is from institutional clients. For more information, please visit www.lakemore.com.

Lakemore Partners Ltd. is the group parent and is domiciled in the Cayman Islands. Lakemore Partners Management US LLC and Lakemore Partners (UK) Ltd. are registered with the U.S. Securities & Exchange Commission as investment advisers (RIA). Lakemore Partners (UK) Ltd. (FRN: 837603) is also an appointed representative of Kroll Securities Ltd. (FRN: 466588), which is authorized and regulated by the Financial Conduct Authority. Lakemore Partners (DIFC) Ltd. is regulated by the Dubai Financial Services Authority. Lakemore Partners Management US LLC, Lakemore Partners (UK) Ltd., and Lakemore Partners (DIFC) Ltd. are wholly owned subsidiaries of Lakemore Partners Ltd.

Media contacts:
Doug Allen/Josh Gerth
Dukas Linden Public Relations
lakemore@dlpr.com
+1 (646) 722-6530

‫فوکسڈ فوٹونکس انکارپوریشن نے اپنی ڈسکلوژر مینجمنٹ ضروریات کے لئے وولٹرز کلوور سی سی ایچ® ٹیگیٹک ماہرانہ حل کا انتخاب کیا ہے

سی سی ایچ ٹیگیٹک کو ایف پی آئیز کی تعمیل کی صلاحیتوں کو مزید بڑھانے کے لئے بہترین حل کے طور پر منتخب کیا گیا نیویارک، 9 اگست 2022 /پی آر نیوزوائر/ — وولٹرز کلوور، پیشہ ورانہ معلومات، سافٹ ویئر حل اور خدمات میں عالمی رہنما، نے آج اعلان کیا ہے کہ فوکسڈ فوٹونکس انکارپوریشن […]

سی سی ایچ ٹیگیٹک کو ایف پی آئیز کی تعمیل کی صلاحیتوں کو مزید بڑھانے کے لئے بہترین حل کے طور پر منتخب کیا گیا

نیویارک، 9 اگست 2022 /پی آر نیوزوائر/ — وولٹرز کلوور، پیشہ ورانہ معلومات، سافٹ ویئر حل اور خدمات میں عالمی رہنما، نے آج اعلان کیا ہے کہ فوکسڈ فوٹونکس انکارپوریشن (ایف پی آئی) نے اپنی سالانہ فائلنگ، بورڈ بک اور مینجمنٹ رپورٹنگ کو آسان بنانے کے لئے سی سی ایچ® ٹیگیٹک ڈسکلوزر مینجمنٹ ایکسپرٹ حل کو اپنایا ہے۔ چینی شراکت دار ای پی ایم وینس مشترکہ طور پر اس منصوبے کی قیادت کریں گے۔https://mma.prnewswire.com/media/1441883/Wolters_Kluwer_Logo.jpg

گیس کی پیمائش اور اخراج، محیطی ہوا اور گندے پانی کی نگرانی میں ایک لیڈر کی حیثیت سے، ایف پی آئی اعلیٰ ترین حفاظتی اقدامات اور ماحولیاتی تحفظ فراہم کرکے اپنے صارفین پر توجہ مرکوز کئے ہوئے ہے۔ ایف پی آئی کی تیزی سے توسیع کے ساتھ، اس نے تسلیم کیا کہ ڈسکلوژر مینجمنٹ جسے دستی (مینوئل) طور پر مکمل کیا جاتا تھا اب گروپ کی ضروریات کو پورا نہیں کر سکتا۔ ایف پی آئی نے مختلف ڈسکلوژر مینجمنٹ سافٹ ویئر حل کا جائزہ لیا ہے اور گاہکوں کے تجربے اور دکانداروں کی ساکھ میں اپنی قیادت کے لئے سی سی ایچ ٹیگیٹک کا انتخاب کیا ہے۔

ایف پی آئی کے فنانشل انفو ٹیکنالوجی کے سربراہ ہی سونگ فانگ نے کہا کہ سی سی ایچ ٹیگیٹک نے ہمارے کام کی کارکردگی کو بہت بہتر بنا کر ڈسکلوژر مینجمنٹ کے لئے ہماری ضروریات کو پورا کیا ہے۔ سی سی ایچ ٹیگیٹک نے کثیر سطحی اور کثیر جہتی استحکام کا بنیادی ڈھانچہ قائم کرکے کارپوریٹ استحکام کے تقاضوں کو پورا کیا ہے، ایم اینڈ اے کے بعد تنظیم کے ڈھانچے کی لچکدار ایڈجسٹمنٹ کی حمایت کی ہے اور بعد میں ملٹی کیلیبر مینجمنٹ کی مضبوطی اور کثیر جہتی تجزیے کی بنیاد رکھی ہے۔

وولٹرز کلوور میں سی سی ایچ ٹیگیٹک،گریٹر چائنا کے جنرل منیجر مائیکل چنگ نے کہا کہ ہمیں خوشی ہے کہ سی سی ایچ ٹیگیٹک ماہر حل کو مارکیٹ میں اچھی طرح تسلیم کیا گیا ہے۔  ہم اپنے صارفین کے ساتھ مل کر کام کرتے رہیں گے، انہیں پیشہ ورانہ حل فراہم کریں گے اور ان کے لئے زیادہ قدر و قیمت پیدا کریں گے۔

اس پروجیکٹ میں ای پی ایم وینس کو گاہکوں کی  ضروریات کی گہری سمجھ کی بنیاد پر اس پر عمل درآمد کے لئے منتخب کیا گیا تھا۔ چین میں سی سی ایچ ٹیگیٹک کے شراکت دار کی حیثیت سے ای پی ایم وینس مینجمنٹ کنسلٹنگ سے لے کر سسٹم سلیکشن کے نفاذ، پروجیکٹ مینجمنٹ اور تربیت تک اینڈ ٹو اینڈ سروسز فراہم کرتا ہے۔

ای پی ایم وینس کے پروجیکٹ منیجر وانگ جون نے کہا کہ ہمیں سی سی ایچ ٹیگیٹک کے نفاذ کے لیے ایف پی آئی کے ساتھ مل کر کام کرنے پر فخر محسوس کرتے ہیں۔ انہوں نے کہا کہ جب اعلی آٹومیشن ریٹ، متعدد اور پیچیدہ ای آر پی سسٹمز کی ضروریات کا سامنا کرنا پڑا تو ہماری ٹیم نے تبدیلی اور استحکام کے لئے مختلف حل تجویز کیے اور سافٹ ویئر کو آسانی سے نافذ کیا اور گاہکوں کو اس کے معیار اور کارکردگی کو بہتر بنانے میں مدد کی۔ مستقبل میں، ہمیں امید ہے کہ ہم سی سی ایچ ٹیگیٹک کے ساتھ مل کر مالیاتی ڈیجیٹل تبدیلی کے حصول کے لیے مزید کمپنیوں کی مدد کریں گے۔

سی سی ایچ® ٹیگیٹک ایک عالمی ماہرانہ حل ہے جو محکمہ خزانہ کو ڈیجیٹل تبدیلی کے حصول کے لیے بااختیار بناتا ہے، فنانشل کلوز اور استحکام، مالی اور آپریشنل منصوبہ بندی اور ریگولیٹری تعمیل کے لئے ایک اسٹرٹیجک اور ذہین پلیٹ فارم فراہم کرتا ہے۔جدید انٹیلیجنٹ مشینوں کو سرایت کرکے صارفین  پیشن گوئی کی صلاحیتوں اور ایک کھلے پلیٹ فارم کے ساتھ فیصلہ سازی کے عمل کو تیز کرسکتے ہیں جو پورے انٹرپرائز میں ڈیٹا اور آپریشنل حل کو جوڑتا ہے۔

وولٹرز کلوور کے بارے میں

وولٹرز کلوور (ڈبلیو کے ایل) صحت کی دیکھ بھال (ہیلتھ کیئر) کے لئے پیشہ ورانہ معلومات، سافٹ ویئر حل اور خدمات میں ایک عالمی رہنما ہے؛ ٹیکس اور اکاؤنٹنگ؛ حکمرانی، خطرہ اور تعمیل؛ اور قانونی اور ریگولیٹری شعبے۔ہم اپنے صارفین کو ہر روز ماہرانہ حل فراہم کرکے اہم فیصلے کرنے میں مدد کرتے ہیں جو گہرے ڈومین معلومات کو جدید ٹیکنالوجی اور خدمات کے ساتھ جوڑتے ہیں۔

وولٹرز کلوور کی 2021 کی سالانہ آمدنی 4.8 € ارب رپورٹ ہوئی ہے۔ یہ گروپ 180 سے زائد ممالک میں صارفین کی خدمت کرتا ہے، 40 سے زائد ممالک میں کام کرتا ہے اور دنیا بھر میں تقریبا 19,800 افراد کو روزگار فراہم کرتا ہے۔ اس کمپنی کا ہیڈ کوارٹر نیدرلینڈز کے شہر الفین عین ڈین رجن میں واقع ہے۔

وولٹرز کلوور کے حصص یورونیکسٹ ایمسٹرڈیم (ڈبلیو کے ایل) پر درج ہیں اور اے ای ایکس اور یورونیکسٹ 100 انڈیکس میں شامل ہیں۔ وولٹرز کلوور کا ایک سپانسرڈ لیول 1 امریکن ڈپازٹری رسیپٹ (اے ڈی آر) پروگرام ہے۔ اے ڈی آرز کا کاروبار امریکہ (ڈبلیو ٹی کے ڈبلیو وائی) میں اوور دی کاؤنٹر مارکیٹ میں کیا جاتا ہے۔

www.wolterskluwer.com مزید معلومات کے لئے ملاحظہ کریں:

ہمیں ٹویٹر، فیس بک، لنکڈ ان اور یوٹیوب پر فالو کریں۔

لوگو۔ https://mma.prnewswire.com/media/1441883/Wolters_Kluwer_Logo.jpg

Konstantinos Fakiolas Named Business Development Manager for Nikkiso Clean Energy and Industrial Gases Group Europe

TEMECULA, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Konstantinos Fakiolas has been named Business Development Manager for the Group’s Cryogenic Pumps Unit. Kostas is a Naval Architect & Marine […]

TEMECULA, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Konstantinos Fakiolas has been named Business Development Manager for the Group’s Cryogenic Pumps Unit.

Kostas is a Naval Architect & Marine Engineer, MSc, MBA, graduate from the National Technical University of Athens Greece, with 24 years of specialization in ship technological applications involving LNG systems, environmental technologies, renewables and energy efficiency.

He has been working closely with Technology providers for their marine business development, while extensively engaged with Asian Shipyards for new building and existing ship upgrade contract negotiations and project management.

Throughout his career he has been occupied as a ship designer, ship surveyor for flag administrations, newbuilding field supervisor, newbuilding contracts project manager, international sales director and business development partner for technology providers acting on global scale.

In this role, he will be managing and implementing a global business development strategy toward growing and expanding Nikkiso Clean Energy products portfolio, solutions and services in the marine market segment. This strategy includes increasing competitiveness and applicability in marine projects, product development and management, and strategic collaboration with industrial partners. Kostas will be based in Europe and will be reporting directly to Mike Wells, Technical Sales Manager, Business Development, Nikkiso Clean Energy & Industrial Gases Group Pumps Unit.

“Konstantinos’ extensive experience, contacts, industry and market knowledge will be instrumental in developing new opportunities in the Marine market and better serving our customers,” according to Ole Jensen, Vice President, NCEIG Europe.

With this addition, Nikkiso continues their commitment to be both a global and local presence for their customers.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture and service engineered cryogenic gas processing equipment (pumps, turboexpanders, heat exchangers, etc.), and process plants for Industrial Gases, Natural gas Liquefaction (LNG), Hydrogen Liquefaction (LH2) and Organic Rankine Cycle for Waste Heat Recovery. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Nikkiso Cryo, Nikkiso Integrated Cryogenic Solutions, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.NikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

LeddarTech Brings Raw Data Fusion and Perception Technology to Automotive ADAS and AD Events in China and the U.S.

QUEBEC CITY, Aug. 10, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce a series of events in China and the United States focused on demonstrating their newest technology, LeddarVision™, a unique raw data fusion and perception solution. LeddarTech’s […]

QUEBEC CITY, Aug. 10, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce a series of events in China and the United States focused on demonstrating their newest technology, LeddarVision™, a unique raw data fusion and perception solution.

LeddarTech’s use of raw data fusion detects very small obstacles on the road with better detection rates and fewer false alarms than legacy “object fusion” solutions. In addition, unclassified obstacles are also detected, providing an additional layer of safety to the vehicle.

LeddarVision is a flexible, robust, cost-effective, sensor-agnostic and scalable auto-grade solution that delivers highly accurate 3D environmental models. In addition, the software supports all SAE autonomy levels by applying AI and computer vision algorithms to fuse raw data from sensors employed in L2-L5 applications.

12th New Energy Vehicle International Forum 2022 August 18-19 Suzhou, China

The 12th edition of this conference and exhibition on new vehicle technologies and design brings together hundreds of VIPs and high-quality industry participants from 15+ countries and 50+ esteemed speakers.

LeddarTech presents “Solving Key ADAS/AD Perception Challenges — Raw Data Fusion and Perception Technology.”

When: August 18, 2022, 12:00-12:30 CST (China standard time).

Where: Shangri-La Hotel, Suzhou, China.

Register here.

ADAS & Autonomous Vehicle Technology Expo and Conference – September 7-8 – San Jose, USA

This new ADAS & AV tech expo features products and solutions for developing and building next-generation connected and fully autonomous vehicles.

LeddarVision showcase (booth #1052): Engineers from Israel and North America will demonstrate how raw data fusion technology simplifies complex sensor sets and eliminates the dependency on hardware to provide customers the flexibility to scale and deliver greater ADAS and AD performance quickly.

When: September 7-8, 2022.

Where: San Jose McEnery Convention Center, San Jose, USA.

Booth: 1052

Register here.

Visit here to learn where else LeddarTech is in the world.

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from Level 2 ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and Tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer™ digital beam steering and the LeddarEngine™, which is built on LeddarTech’s Leddar™ technology employing patented signal acquisition and processing techniques to generate a richer and cleaner return signal at a lower cost. The LeddarEngine comprises a highly integrated, scalable LiDAR SoC and software combination that enables LiDAR developers and Tier 1-2 automotive suppliers to design their own LiDAR solutions. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 120 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Investor relations contact: InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Anna Mizell Named EPC Direct Sales Manager for Nikkiso Clean Energy and Industrial Gases Group

TEMECULA, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Anna Mizell has been named EPC Direct Sales Manager for the Group’s Cryogenic Pumps Unit. Anna is an experienced technical sales […]

TEMECULA, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Anna Mizell has been named EPC Direct Sales Manager for the Group’s Cryogenic Pumps Unit.

Anna is an experienced technical sales professional, with focus on the Gulf Coast and East Coast regions. A mechanical engineer by education, she will be responsible for supporting EPCs throughout the United States with Cryogenic Pumps as well as other Group products, service and support. She has most recently been a Sales Manager and Sales Engineer for Sundyne. She will be reporting directly to Ian Guthrie, Business Line Manager for the Group’s Cryogenic Pumps unit.

“The Pumps Unit is excited to have Anna in this new strategic management role,” according to Daryl Lamy, President and CEO of the Group’s Pump Unit. “Her years of experience will add to our ability to offer world-class cryogenic pump products, customer service and value-added solutions for our customers.”

Nikkiso Cryogenic Pumps Unit which includes Nikkiso ACD and Nikkiso Cryo is a leading manufacturer of a diverse line of cryogenic pumps – large to small.

With this addition, Nikkiso continues their commitment to be both a global and local presence for their customers.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture and service engineered cryogenic gas processing equipment (pumps, turboexpanders, heat exchangers, etc.), and process plants for Industrial Gases, Natural Gas Liquefaction (LNG), Hydrogen Liquefaction (LH2) and Organic Rankine Cycle for Waste Heat Recovery. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Nikkiso Cryo, Nikkiso Integrated Cryogenic Solutions, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

MOLN LOSS ALERT: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Molecular Partners AG Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MOLN

NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s initial public offering conducted on or about June 16, 2021 (the “IPO”); […]

NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s initial public offering conducted on or about June 16, 2021 (the “IPO”); and/or (ii) between June 16, 2021 and April 26, 2022, both dates inclusive (the “Class Period”), of the important September 12, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Molecular Partners securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Molecular Partners class action, go to https://rosenlegal.com/submit-form/?case_id=7548 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 12, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the IPO documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, the complaint alleges that, throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the IPO documents and defendants made false and/or misleading statements and/or failed to disclose that: (1) ensovibep was less effective at treating COVID-19 than defendants had led investors to believe; (2) accordingly, the U.S. Food and Drug Administration (“FDA”) was reasonably likely to require an additional Phase 3 study of ensovibep before granting the drug Emergency Use Authorization (“EUA”); (3) waning global rates of COVID-19 significantly reduced the Company’s chances of securing EUA for ensovibep; (4) as a product candidate, MP0310 (AMG 506), in development for the treatment of certain types of cancer,  was less attractive to Amgen Inc. (“Amgen”) than defendants had led investors to believe; (5) accordingly, there was a significant likelihood that Amgen would return global rights of MP0310 to Molecular Partners; (6) as a result of all the foregoing, the clinical and commercial prospects of ensovibep and MP0310 were overstated; and (7) as a result, the IPO documents and defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Molecular Partners class action, go to https://rosenlegal.com/submit-form/?case_id=7548 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com